Sign In
Buy CBAY
$32.48
+0 (+0%)
At Close: Apr 11, 2024
The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
11:37am, Thursday, 12'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 11)
Bicycle Therapeutics...
Citigroup Inc. Buys 355,463 Shares of CymaBay Therapeutics Inc (NASDAQ:CBAY)
10:50am, Thursday, 12'th Mar 2020
Citigroup Inc. boosted its stake in shares of CymaBay Therapeutics Inc (NASDAQ:CBAY) by 35.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and
The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
12:00am, Thursday, 12'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 11)
Bicycle Therapeutics...
SAN FRANCISCO, CA / ACCESSWIRE / March 11, 2020 / Hagens Berman urges investors in CymaBay Therapeutics, Inc. (NASDAQ:CBAY) who have suffered significant losses to submit their losses now . The firm i
LOS ANGELES, CA / ACCESSWIRE / March 10, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CymaBay Therapeu
Is the Options Market Predicting a Spike in CymaBay Therapeutics (CBAY) Stock?
12:44pm, Tuesday, 10'th Mar 2020
Investors need to pay close attention to CymaBay Therapeutics (CBAY) stock based on the movements in the options market lately.
Is the Options Market Predicting a Spike in CymaBay Therapeutics (CBAY) Stock?
12:44pm, Tuesday, 10'th Mar 2020
Investors need to pay close attention to CymaBay Therapeutics (CBAY) stock based on the movements in the options market lately.
CymaBay Therapeutics (CBAY) to Release Quarterly Earnings on Thursday
07:32am, Tuesday, 10'th Mar 2020
CymaBay Therapeutics (NASDAQ:CBAY) is scheduled to be announcing its earnings results after the market closes on Thursday, March 12th. Analysts expect the company to announce earnings of ($0.39) per s
CymaBay Therapeutics Inc (NASDAQ:CBAY) Expected to Announce Earnings of -$0.37 Per Share
05:44am, Tuesday, 10'th Mar 2020
Wall Street analysts expect CymaBay Therapeutics Inc (NASDAQ:CBAY) to announce earnings per share (EPS) of ($0.37) for the current quarter, according to Zacks Investment Research. Zero analysts have m
Is the Options Market Predicting a Spike in CymaBay Therapeutics (CBAY) Stock?
12:00am, Tuesday, 10'th Mar 2020
Hagens Berman urges investors in CymaBay Therapeutics, Inc. (CBAY) who have suffered significant losses to submit their losses now. The investigation concerns the veracity of CymaBay’s disclosures
LOS ANGELES, CA / ACCESSWIRE / March 9, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CymaBay Therapeut
ROSEN, A LEADING LAW FIRM, Announces Investigation of Securities Claims Against CymaBay Therapeutics, Inc. – CBAY
02:57pm, Monday, 09'th Mar 2020
NEW YORK, March 09, 2020 -- Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of CymaBay.
Stocks To Watch: Fading The Fear
12:07pm, Saturday, 07'th Mar 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th
4 Smaller, Cash-Rich Biotech Stocks That Could Be Safe Havens
03:49pm, Friday, 06'th Mar 2020
“A volatile, risk-off environment could make these relative outperformers,” writes Jeffries’ Michael Yee.
